Ahmad Al Khleifat1, Rubika Balendra2,3, Ton Fang1, Ammar Al-Chalabi1,4. 1. Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK. 2. Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. 3. Department of Genetics, Evolution and Environment, Institute of Healthy Ageing, University College London, London, UK. 4. Department of Neurology, King's College Hospital, London, UK.
Abstract
Background: Clinical stage in amyotrophic lateral sclerosis (ALS) can be assigned using King's staging with a simple protocol based on the number of CNS regions involved and the presence of significant nutritional or respiratory failure. It is important that the assigned clinical stage matches expectations, and generally corresponds with how a health care professional would intuitively stage the patient. We therefore investigated the relationship between King's clinical ALS stage and ALS stage as intuitively assigned by health care professionals. Methods: We wrote 17 case vignettes describing people with ALS at different disease stages from very early limited disease involvement through to severe, multi-domain disease. During two workshops, we asked health care professionals to intuitively stage the vignettes and compared the answers with the actual King's clinical ALS stage. Results: There was a good correlation between King's clinical ALS stage and intuitively assigned stage, with a Spearman's Rank correlation coefficient of 0.64 (p < 0.001). There was no difference in the intuitive stages assigned by practitioners of different types or at different levels of experience. Conclusions: Across a spectrum of ALS scenarios, King's clinical ALS stage corresponds to intuitive ALS stage as assigned by a range of health care professionals.
Background: Clinical stage in amyotrophic lateral sclerosis (ALS) can be assigned using King's staging with a simple protocol based on the number of CNS regions involved and the presence of significant nutritional or respiratory failure. It is important that the assigned clinical stage matches expectations, and generally corresponds with how a health care professional would intuitively stage the patient. We therefore investigated the relationship between King's clinical ALS stage and ALS stage as intuitively assigned by health care professionals. Methods: We wrote 17 case vignettes describing people with ALS at different disease stages from very early limited disease involvement through to severe, multi-domain disease. During two workshops, we asked health care professionals to intuitively stage the vignettes and compared the answers with the actual King's clinical ALS stage. Results: There was a good correlation between King's clinical ALS stage and intuitively assigned stage, with a Spearman's Rank correlation coefficient of 0.64 (p < 0.001). There was no difference in the intuitive stages assigned by practitioners of different types or at different levels of experience. Conclusions: Across a spectrum of ALS scenarios, King's clinical ALS stage corresponds to intuitive ALS stage as assigned by a range of health care professionals.
Authors: Patrick Oeckl; Claude Jardel; François Salachas; Foudil Lamari; Peter M Andersen; Robert Bowser; Mamede de Carvalho; Júlia Costa; Philip van Damme; Elizabeth Gray; Julian Grosskreutz; María Hernández-Barral; Sanna-Kaisa Herukka; André Huss; Andreas Jeromin; Janine Kirby; Magdalena Kuzma-Kozakiewicz; Maria Del Mar Amador; Jesús S Mora; Claudia Morelli; Petra Muckova; Susanne Petri; Koen Poesen; Heidrun Rhode; Anna-Karin Rikardsson; Wim Robberecht; Ana I Rodríguez Mahillo; Pamela Shaw; Vincenzo Silani; Petra Steinacker; Martin R Turner; Erdem Tüzün; Berrak Yetimler; Albert C Ludolph; Markus Otto Journal: Amyotroph Lateral Scler Frontotemporal Degener Date: 2016-04-11 Impact factor: 4.092
Authors: Ammar Al-Chalabi; Orla Hardiman; Matthew C Kiernan; Adriano Chiò; Benjamin Rix-Brooks; Leonard H van den Berg Journal: Lancet Neurol Date: 2016-10 Impact factor: 44.182
Authors: Johanna Gaiottino; Niklas Norgren; Ruth Dobson; Joanne Topping; Ahuva Nissim; Andrea Malaspina; Jonathan P Bestwick; Andreas U Monsch; Axel Regeniter; Raija L Lindberg; Ludwig Kappos; David Leppert; Axel Petzold; Gavin Giovannoni; Jens Kuhle Journal: PLoS One Date: 2013-09-20 Impact factor: 3.240
Authors: Jonathan A Knibb; Noa Keren; Anna Kulka; P Nigel Leigh; Sarah Martin; Christopher E Shaw; Miho Tsuda; Ammar Al-Chalabi Journal: J Neurol Neurosurg Psychiatry Date: 2016-07-04 Impact factor: 10.154